New Johns Hopkins process tackles dementia symptoms

Laura Gitlin, Ph.D.
Laura Gitlin, Ph.D.

A new six-step approach from Johns Hopkins University School of Nursing professors outlines management of behavioral symptoms in dementia.

Managing residents with dementia in a long-term care environment can be a challenge for healthcare providers, as symptoms may include confusion and wandering. In addition to causing distress to the resident and family, the behavior changes create risk. 

The approach, outlined in the Nov. 21 Journal of the American Medical Association Clinician's Corner, is:

• Screen for behavioral symptoms early.

• Identify symptoms.

• Delineate the triggers and risk factors for the symptoms.

• Choose the proper interventions. For example, an individual with dementia might wake repeatedly each night, voicing fear of being alone in the dark, despite continuous calming efforts. An intervention might mean simply using a nightlight in the patient's room, or adding long family walks in the evening to help promote better sleep.

• Evaluate the intervention to make sure it's working.

• Follow patient progress.

The process should be done “in any clinical setting involved in caring for someone with dementia, including primary care and memory clinics, as well as in hospitals, assisted living and nursing facilities,” notes Hopkins professor Laura N. Gitlin, Ph.D. 

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.